<DOC>
	<DOCNO>NCT01267461</DOCNO>
	<brief_summary>Recently general medical literature become aware use certain long-acting insulin analogue could potentially increase cancer risk.During last year investigator group generate information scientific clinical relevance proliferative anti-apoptotic action insulin analogue . The goal project evaluate hypothesis proliferative signalling activity elicit insulin analogue may impact tumor behavior . In study investigator asses biological action insulin analog primary tumor cell endometrial colon cancer .</brief_summary>
	<brief_title>Evaluation Proliferative Activities Insulin Analogues Primary Human Tumor Cells</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Patients Endometrial Colon Cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>To asses biological action insulin analog primary tumor cell</keyword>
</DOC>